Eugia receives FDA approval for Ertapenem for Injection!
Published: June 26, 2018
On June 25, 2018 Eugia received FDA approval for Ertapenem for Injection which is indicated for treatment of moderate to severe infections caused by susceptible bacteria.
This approved product has an estimated market size of $387 million for the twelve months ending April 2018 according to IMS.